Additional findings from this study highlighted the interlink between fluctuating PI-PLCβ1 expression and Akt activity, which could impact the cell cycle in MDS cells, ultimately inhibiting apoptosis while enhancing MDS cell survival. This evidence concerns the gene AKT1 and myelodysplastic syndrome.